These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11307619)

  • 1. Alzheimer morphology is not increased in dialysis-associated encephalopathy and long-term hemodialysis.
    Reusche E; Koch V; Lindner B; Harrison AP; Friedrich HJ
    Acta Neuropathol; 2001 Mar; 101(3):211-6. PubMed ID: 11307619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argyrophilic inclusions distinct from Alzheimer neurofibrillary changes in one case of dialysis-associated encephalopathy.
    Reusche E
    Acta Neuropathol; 1997 Dec; 94(6):612-6. PubMed ID: 9444364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysis-associated encephalopathy: light and electron microscopic morphology and topography with evidence of aluminum by laser microprobe mass analysis.
    Reusche E; Seydel U
    Acta Neuropathol; 1993; 86(3):249-58. PubMed ID: 8213083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
    Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
    J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Alzheimer neurofibrillary tangles show beta-amyloid-like immunoreactivity.
    Sherriff FE; Bridges LR; De Souza DS
    Neuroreport; 1994 Oct; 5(15):1897-900. PubMed ID: 7531003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistry.
    Fujino Y; Wang DS; Thomas N; Espinoza M; Davies P; Dickson DW
    J Neuropathol Exp Neurol; 2005 Mar; 64(3):209-14. PubMed ID: 15804052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered?
    Savory J; Exley C; Forbes WF; Huang Y; Joshi JG; Kruck T; McLachlan DR; Wakayama I
    J Toxicol Environ Health; 1996 Aug; 48(6):615-35. PubMed ID: 8772802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
    Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
    Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure.
    Candy JM; McArthur FK; Oakley AE; Taylor GA; Chen CP; Mountfort SA; Thompson JE; Chalker PR; Bishop HE; Beyreuther K
    J Neurol Sci; 1992 Feb; 107(2):210-8. PubMed ID: 1564520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles.
    Hunter S; Minett T; Polvikoski T; Mukaetova-Ladinska E; Brayne C;
    Alzheimers Res Ther; 2015 Aug; 7(1):57. PubMed ID: 26315613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease.
    Botez G; Probst A; Ipsen S; Tolnay M
    Acta Neuropathol; 1999 Sep; 98(3):251-6. PubMed ID: 10483782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminum induces tau aggregation in vitro but not in vivo.
    Mizoroki T; Meshitsuka S; Maeda S; Murayama M; Sahara N; Takashima A
    J Alzheimers Dis; 2007 Jul; 11(4):419-27. PubMed ID: 17656819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert.
    Sassin I; Schultz C; Thal DR; Rüb U; Arai K; Braak E; Braak H
    Acta Neuropathol; 2000 Sep; 100(3):259-69. PubMed ID: 10965795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
    Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
    Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional quantitative analysis of tau-positive neurons in progressive supranuclear palsy: comparison with Alzheimer's disease.
    Li F; Iseki E; Odawara T; Kosaka K; Yagishita S; Amano N
    J Neurol Sci; 1998 Jul; 159(1):73-81. PubMed ID: 9700707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease.
    Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer-type lesions in Huntington's disease.
    Jellinger KA
    J Neural Transm (Vienna); 1998; 105(8-9):787-99. PubMed ID: 9869319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.